Literature DB >> 34424560

Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist.

Juliana Perez Botero1,2, Jessica A Reese3, James N George3,4, Jennifer J McIntosh5.   

Abstract

A hematologist receives a call from a maternal-fetal medicine (MFM) physician about a previously healthy patient who became ill at 25 weeks' gestation. Her mental status is deteriorating. There are signs of fetal distress. Platelet count and hemoglobin are falling. The MFM physician is considering the hemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome. For the hematologist, everything seems unfamiliar. Our goal is to provide hematologists with the fundamental knowledge required for understanding and managing these patients who become suddenly and seriously ill during pregnancy and in whom thrombocytopenia and microangiopathic hemolytic anemia are part of their presentation.
© 2021 Wiley Periodicals LLC.

Entities:  

Mesh:

Year:  2021        PMID: 34424560      PMCID: PMC8616841          DOI: 10.1002/ajh.26328

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  61 in total

1.  Congenital thrombotic thrombocytopenic purpura related to a novel mutation in ADAMTS13 gene and management during pregnancy.

Authors:  Narendranath Epperla; Kathleen Hemauer; Kenneth D Friedman; James N George; Patrick Foy
Journal:  Am J Hematol       Date:  2016-06       Impact factor: 10.047

2.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

3.  Additional autoimmune disorders in patients with acquired autoimmune thrombotic thrombocytopenic purpura.

Authors:  Ayesha Hassan; Madiha Iqbal; James N George
Journal:  Am J Hematol       Date:  2019-04-01       Impact factor: 10.047

4.  Drug-induced thrombotic microangiopathy: An updated systematic review, 2014-2018.

Authors:  Rabia Saleem; Jessica A Reese; James N George
Journal:  Am J Hematol       Date:  2018-08-06       Impact factor: 10.047

Review 5.  Syndromes of thrombotic microangiopathy.

Authors:  James N George; Carla M Nester
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

6.  Clinical morbidities, trends, and demographics of eclampsia: a population-based study.

Authors:  Alex Fong; Cindy Tung Chau; Deyu Pan; Dotun Adeboye Ogunyemi
Journal:  Am J Obstet Gynecol       Date:  2013-05-30       Impact factor: 8.661

7.  American Society of Hematology 2019 guidelines for immune thrombocytopenia.

Authors:  Cindy Neunert; Deirdra R Terrell; Donald M Arnold; George Buchanan; Douglas B Cines; Nichola Cooper; Adam Cuker; Jenny M Despotovic; James N George; Rachael F Grace; Thomas Kühne; David J Kuter; Wendy Lim; Keith R McCrae; Barbara Pruitt; Hayley Shimanek; Sara K Vesely
Journal:  Blood Adv       Date:  2019-12-10

8.  Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura.

Authors:  Erika Tarasco; Lukas Bütikofer; Kenneth D Friedman; James N George; Ingrid Hrachovinova; Paul N Knöbl; Masanori Matsumoto; Anne Sophie von Krogh; Isabella Aebi-Huber; Zuzana Cermakova; Magdalena Górska-Kosicka; Katarzyna A Jalowiec; Carlo R Largiadèr; Zoltán Prohászka; György Sinkovits; Jerzy Windyga; Bernhard Lämmle; Johanna A Kremer Hovinga
Journal:  Blood       Date:  2021-06-24       Impact factor: 22.113

9.  Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab.

Authors:  Senthil Sukumar; James N George; Spero R Cataland
Journal:  Am J Hematol       Date:  2020-01-14       Impact factor: 13.265

Review 10.  Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? An expert review of the literature.

Authors:  Jasmine D Johnson; Judette M Louis
Journal:  Am J Obstet Gynecol       Date:  2020-07-24       Impact factor: 8.661

View more
  4 in total

1.  Chronic active Epstein-Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report.

Authors:  Masaya Takahashi; Shintaro Makino; Hiroko Iizuka; Masaaki Noguchi; Koyo Yoshida
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-07       Impact factor: 3.007

2.  Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura.

Authors:  Azra Borogovac; Jessica A Reese; Samiksha Gupta; James N George
Journal:  Blood Adv       Date:  2022-02-08

Review 3.  Vascular Dysfunction in Preeclampsia.

Authors:  Megan A Opichka; Matthew W Rappelt; David D Gutterman; Justin L Grobe; Jennifer J McIntosh
Journal:  Cells       Date:  2021-11-06       Impact factor: 7.666

4.  A Race against the Clock: A Case Report and Literature Review Concerning the Importance of ADAMTS13 Testing in Diagnosis and Management of Thrombotic Thrombocytopenic Purpura during Pregnancy.

Authors:  Melinda Ildiko Mitranovici; Lucian Pușcașiu; Ioan Emilian Oală; Izabella Petre; Marius Lucian Craina; Antonia Rebeka Mager; Kinga Vasile; Diana Maria Chiorean; Adrian-Horațiu Sabău; Sabin Gligore Turdean; Ovidiu Simion Cotoi
Journal:  Diagnostics (Basel)       Date:  2022-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.